Cargando…
The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies
The successful outcomes of chimeric antigen receptor (CAR) T-cell therapy in treating hematologic cancers have increased the previously unprecedented excitement to use this innovative approach in treating various forms of human cancers. Although researchers have put a lot of work into maximizing the...
Autores principales: | Daei Sorkhabi, Amin, Mohamed Khosroshahi, Leila, Sarkesh, Aila, Mardi, Amirhossein, Aghebati-Maleki, Ali, Aghebati-Maleki, Leili, Baradaran, Behzad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067596/ https://www.ncbi.nlm.nih.gov/pubmed/37020537 http://dx.doi.org/10.3389/fimmu.2023.1113882 |
Ejemplares similares
-
Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice
por: Daei Sorkhabi, Amin, et al.
Publicado: (2023) -
Current status of skin cancers with a focus on immunology and immunotherapy
por: Khayyati Kohnehshahri, Mahsa, et al.
Publicado: (2023) -
Current applications and prospects of nanoparticles for antifungal drug delivery
por: Nami, Sanam, et al.
Publicado: (2021) -
Phage display as a promising approach for vaccine development
por: Aghebati-Maleki, Leili, et al.
Publicado: (2016) -
Generation and Characterization of Anti-CD34
Monoclonal Antibodies that React with
Hematopoietic Stem Cells
por: Aghebati Maleki, Leili, et al.
Publicado: (2014)